As of today (2024-05-25), Acino Holding AG's share price is €93.92.
Acino Holding AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2013 was €0.57. Hence, Acino Holding AG's Price-to-Free-Cash-Flow Ratio for today is 164.48.
The historical rank and industry rank for Acino Holding AG's Price-to-Free-Cash-Flow or its related term are showing as below:
FRA:S3H'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 1.09 Med: 26.5 Max: 163.94
Current: 160
During the past 11 years, Acino Holding AG's highest Price-to-Free-Cash-Flow Ratio was 163.94. The lowest was 1.09. And the median was 26.50.
FRA:S3H's Price-to-Free-Cash-Flow is not ranked
in the Drug Manufacturers industry.
Industry Median: 23.77
vs FRA:S3H: 160.00
During the past 11 years, Acino Holding AG's highest 3-Year average Free Cash Flow per Share Growth Rate was 51.90% per year. The lowest was 0.00% per year. And the median was -80.10% per year.
Acino Holding AG Price-to-Free-Cash-Flow Historical Data
The historical data trend for Acino Holding AG's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Acino Holding AG's Price-to-Free-Cash-Flow
For the Drug Manufacturers - General subindustry, Acino Holding AG's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acino Holding AG's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Acino Holding AG's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Acino Holding AG's Price-to-Free-Cash-Flow falls into.
Acino Holding AG Price-to-Free-Cash-Flow Calculation
Acino Holding AG's Price-to-Free-Cash-Flow ratio for today is calculated as
Acino Holding AG's Share Price of today is €93.92.
For company reported annually, GuruFocus uses latest annual data as the TTM data. Acino Holding AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2013 was €0.57.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Acino Holding AG (FRA:S3H) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Acino Holding AG Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Acino Holding AG's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Acino Holding AG is a Switzerland-based company engaged in the pharmaceutical industry. The Company develops, manufactures, and markets pharmaceuticals in novel drug delivery forms internationally. It is divided into four segments Business to Consumer (BtC); Business to Business (BtB); Technology marketing (TM); and Production (Prod). The BtC segment comprises all direct marketing activities. Under the company's "Acino Switzerland" brand and, with the promise of Swiss quality, the company sells its products in emerging markets around the globe. This reporting segment includes the business purchased from Mepha/Cephalon in the Middle East, Africa, Latin America and Asia. The BtB segment comprises Acino's business with its internally developed products, for which the company also owns the intellectual property rights. Acino develops and produces high-quality medicines with proven active ingredients and modern drug delivery systems and grants licenses for them to leading pharmaceutical and generic pharmaceutical companies worldwide. The technology marketing segment comprises a broad spectrum of fully integrated contract services, including procurement, contract development, production and packaging for companies in the life sciences industry. On behalf of these customers, Acino develops a comprehensive product pipeline on the basis of its special technological know-how. This includes both new types of medicines as well as projects with innovative drug delivery systems for established active ingredients. The production segment is responsible for the manufacturing of products and the supplying of the other three segments, and generates turnover through the reimbursement of its services. The manufacturing costs of products are credited to the production segment at standard prices along with remuneration in the form of a mark-up for materials and production costs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:S3H has been successfully added to your 